Korea Arlico Pharm Co.,Ltd. (KOSDAQ: A260660)
Health Care · Pharmaceuticals · KR
₩2,340.00
+3.54% today · -40.7% 1Y
Korea Arlico Pharm Co.,Ltd. (KOSDAQ: A260660) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $26.68M.
Over the last twelve months the share price has lost 40.7%, trading between 2.15K and 5.76K.
Tweenvest scores Korea Arlico Pharm Co.,Ltd. across four factors: quality 62/100, value 69/100, growth 42/100. Its strongest factor is value.
A260660 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $26.68M
- Revenue (TTM)
- $126.37M
- P/E
- —
- EPS
- -190.01
- Dividend yield
- —
- Beta (5Y)
- 0.33
- 52-week high
- ₩5,760.00
- 52-week low
- ₩2,150.00
- Avg volume (3M)
- —
- Shares outstanding
- 15.33M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SymBio Pharmaceuticals LimitedTSE: 4582 | $27.34M | ¥54.00 | -3.57% |
| Seach Medical Group LtdTASE: SEMG | $27.26M | ₪2.60 | -7.71% |
| Lyka Labs LimitedNSEI: LYKALABS | $27.14M | Rs72.65 | -10.91% |
| Botanix Pharmaceuticals LimitedASX: BOT | $26.74M | AU$0.01 | -22.22% |
| Winston Medical Supply Co., Ltd.TPEX: 6817 | $26.38M | NT$45.80 | -2.86% |
| Cessatech A/SNGM: CESSA | $26.25M | Dkr9.30 | +1.75% |
| Earth Science Tech, Inc.OTCPK: ETST | $26.23M | $0.09 | +0.11% |
| Korean Drug Co., Ltd.KOSDAQ: A014570 | $25.89M | ₩3,190.00 | -2.60% |
Figures last refreshed Oct 11, 2026.